Skip to main content

ALCON INC

corporate_fare Company Profile

ALCON INC

ALC·NYSE·Industrial Applications And Services·CIK 0001167379

Alcon is a global leader in eye care, generating $10.3 billion in net sales for the year ended December 31, 2025. The company researches, develops, manufactures, distributes, and sells a full range of eye care products across two main businesses: Surgical and Vision Care. Based on 2025 sales, Alcon holds the number one global market share in both the ophthalmic surgical market and the vision care market. The company employs over 25,000 associates in 56 countries and serves consumers and patients in over 140 countries and territories. Alcon's Surgical business provides ophthalmic products for cataract, vitreoretinal, refractive laser, and glaucoma surgeries. This portfolio includes implantables, consumables, and surgical equipment that support the complete needs of ophthalmic surgeons. The Vision Care business offers daily disposable, reusable, and color-enhancing contact lenses, cell therapies for ocular diseases, and a comprehensive range of ocular health products. These ocular health products include solutions for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. Alcon also provides service, training, education, and technical support to its customers. The Surgical and Vision Care businesses are complementary, benefiting from shared research and development, manufacturing, distribution, and consumer awareness efforts.

ALCON INC (NYSE:ALC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for ALC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for ALC spans 6-K, 20-F.

Recent high-impact activity:

  • Alcon Q2 Sales Climb 8% on New Product Launches; Core Margin and EPS Outlook Raised Despite $402M PowerVision Charge
  • Alcon Q2 Sales Jump 8% to $2.8B, Raises Full-Year Margin and EPS Outlook
  • Alcon Reports Strong Q1 Results, Raises 2026 EPS Outlook, and Authorizes New $1.5B Share Buyback
  • Alcon's Q1 Sales Jump 10%, Core EPS Rises to $0.85; New $1.5B Share Buyback Authorized
  • Alcon Proposes CHF 0.28 Dividend and Elects Former Cisco CFO R. Scott Herren to Board

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$10.4B
Net Income
$980M
Diluted EPS
$1.98
Op. Cash Flow
$2.27B
Free Cash Flow
$1.73B
Gross Profit
$5.75B
Operating Income
$1.36B
Cash & Equivalents
$1.53B
Total Debt
$4.16B
Debt / Equity
0.19×
Net Margin
9.4%
Source: 20-F · filed 2026-02-24 · accession 0001167379-26-000014

Insider Transactions

ALC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with A →
$65.04
52-week range · as of 2026-08-10 $61.84 – $90.41
Market cap
$32.5B
Volume
3.5M (2.0× avg)
3-mo avg 1.7M
Live data · 2026-09-21 00:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ALC - Latest Insights

ALC
Aug 10, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $77.30
Real-time Price: $65.04 info
Change: -$12.26 (-16%) info
Market Cap: $32.5B info
ALC
Aug 10, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $75.03
Real-time Price: $65.04 info
Change: -$9.99 (-13%) info
Market Cap: $32.5B info
ALC
May 05, 2026, 4:35 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $71.85
Real-time Price: $65.04 info
Change: -$6.81 (-9%) info
Market Cap: $32.5B info
ALC
May 05, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $75.92
Real-time Price: $65.04 info
Change: -$10.88 (-14%) info
Market Cap: $32.5B info
ALC
Apr 02, 2026, 4:34 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $74.56
Real-time Price: $65.04 info
Change: -$9.52 (-13%) info
Market Cap: $32.5B info
ALC
Feb 24, 2026, 4:41 PM EST
Filing Type: 20-F
Importance Score:
7
Price at Filing: $80.43
Real-time Price: $65.04 info
Change: -$15.39 (-19%) info
Market Cap: $32.5B info
ALC
Feb 24, 2026, 4:35 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $82.00
Real-time Price: $65.04 info
Change: -$16.96 (-21%) info
Market Cap: $32.5B info
ALC
Jan 06, 2026, 8:19 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $80.21
Real-time Price: $65.04 info
Change: -$15.17 (-19%) info
Market Cap: $32.5B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets